The bat harbored the BRZ batCoV virus, which the researchers say has likely been silently circulating in Latin America for some time. Continue Reading »

Our systematic review published this week shows that rigorous, transparent evidence synthesis can persist even when traditional advisory processes falter. Continue Reading »

But the overall odds are likely low and may well have ebbed since the pandemic peak.  Continue Reading »

The revamped open-access site tracks scientific progress toward the development of broadly protective coronavirus vaccines. Continue Reading »

Participants with schizophrenia, bipolar disorder, or recurrent major depressive disorder were at a 10% higher risk of persistent symptoms. Continue Reading »

The large-scale project was conducted by the Center for Infectious Disease Research and Policy's Vaccine Integrity Project.  Continue Reading »

Flights from Asia played a larger role in disease spread than those from other countries, the study found. Continue Reading »

Overall protection against infections peaked at 4 weeks after vaccination. Continue Reading »

The findings underscore the need to explore alternative therapeutic approaches to managing persistent symptoms, the authors say. Continue Reading »

Immunocompromised adults and children should receive an age-appropriate COVID-19 vaccine dose as soon as possible, the organization says. Continue Reading »

The vaccines appear to sensitize tumors to cancer patients' immune checkpoint inhibitors, the researchers say. Continue Reading »

No increased risk of congenital abnormalities was seen overall, by organ system, or for any of the 75 individual defects studied.  Continue Reading »

The Global Preparedness Monitoring Board says countries need to bolster primary healthcare systems, establish a pandemic risk monitoring system, and strengthen cooperation. Continue Reading »

The excess risk was primarily seen among COVID-19 survivors who were hospitalized for their infections. Continue Reading »

The vaccine was tied to lower risks of the outcomes among all age-groups, regardless of major underlying medical conditions and immune status. Continue Reading »

But there is 'substantial opportunity' for load-balancing strategies during future pediatric hospital surges to reduce bed strain and harm, the authors say. Continue Reading »

The CDC recommends that toddlers receive the varicella (chickenpox) vaccine as a standalone immunization. Continue Reading »

In contrast, the condition affected less than 1% of the Swedish population before the pandemic.  Continue Reading »

The rate of test positivity and percentage of emergency department visits diagnosed as COVID-19 significantly declined in September. Continue Reading »

The authors call for more research to identify patient groups that could benefit from repeated treatment for COVID-19 after symptom and/or viral RNA rebound. Continue Reading »

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 25 October – 1 November 2025, and includes updates on respiratory virus epidemiology in the EU/EEA, chikungunya virus disease, West Nile virus, dengue, Ebola Virus Disease, Rift ... Continue Reading »

RSV and influenza transmission remain low in the EU/EEA; however, circulation for both viruses has begun to increase in some countries. COVID-19 circulation, while still widespread, continues to decrease. Consider getting vaccinated against seasonal respiratory viruses. Continue Reading »

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 18-24 October 2025, and includes updates on respiratory viruses, monkeypox virus clade Ib, Ebola virus disease, dengue, West Nile virus infection, chikungunya virus disease, and expert deployments. Continue Reading »

In this episode of ECDC On Air, we discuss the seasonal spread of respiratory viruses with ECDC's Principal Expert in Respiratory Viruses - Angeliki Melidou. Continue Reading »

Infographic on protecting yourself and the most vulnerable against respiratory viruses. Continue Reading »

Infographic on the risks posed by respiratory viruses and how to protect your community from infection. Continue Reading »

As Europe enters the autumn and winter months, respiratory infections are expected to considerably affect the health of individuals vulnerable to severe outcomes. Continue Reading »

During the first year of the COVID-19 pandemic, vaccination programmes targeted children and adolescents to prevent severe outcomes of SARS-CoV-2 infection.AimTo estimate COVID-19 vaccine effectiveness (VE) against hospitalisation due to COVID-19 in the paediatric population, among those with and without ... Continue Reading »

We estimated XBB.1.5 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection among adults aged ≥ 65 years during the 2023/2024 JN.1 lineage-predominant period in a European multi-country test-negative case-control study at primary care level. Continue Reading »

This interactive dashboard provides a weekly integrated epidemiological summary for influenza, RSV and SARS-CoV-2. Continue Reading »